PROCEPT BioRobotics Overview
- Year Founded
-
2009
- Status
-
Public
- Employees
-
888
- Stock Symbol
-
PRCT
- Share Price
-
$23.82
- (As of Friday Closing)
PROCEPT BioRobotics General Information
Description
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
Contact Information
Website
www.procept-biorobotics.comCorporate Office
- 900 Island Drive
- Suite 170
- Redwood Shore, CA 94065
- United States
Corporate Office
- 900 Island Drive
- Suite 170
- Redwood Shore, CA 94065
- United States
PROCEPT BioRobotics Stock Performance
As of 13-Nov-2026, PROCEPT BioRobotics’s stock price is $23.82. Its current market cap is $1.37B with 57.5M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $23.82 | $23.51 | $16.66 - $38.11 | $1.37B | 57.5M | 1.26M | -$2.02 |
PROCEPT BioRobotics Financials Summary
As of 30-Sep-2026, PROCEPT BioRobotics has a trailing 12-month revenue of $352M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 893,112 | 1,542,585 | 4,240,512 | 1,909,049 |
| Revenue | 352,305 | 308,054 | 224,498 | 136,191 |
| EBITDA | (110,596) | (97,625) | (92,522) | (105,566) |
| Net Income | (114,860) | (95,572) | (91,413) | (105,897) |
| Total Assets | 473,759 | 508,081 | 534,017 | 404,717 |
| Total Debt | 76,992 | 78,483 | 80,250 | 79,204 |
PROCEPT BioRobotics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
PROCEPT BioRobotics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
PROCEPT BioRobotics Comparisons
Industry
Financing
Details
PROCEPT BioRobotics Competitors (14)
One of PROCEPT BioRobotics’s 14 competitors is Encision, a Corporation company based in Boulder, CO.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Encision | Corporation | Boulder, CO | ||||
| Abbott | Corporation | Abbot Park, IL | ||||
| Medtronic | Corporation | Minneapolis, MN | ||||
| CooperSurgical | Corporate Backed or Acquired | Trumbull, CT | ||||
| Stryker | Formerly VC-backed | Portage, MI |
PROCEPT BioRobotics Patents
PROCEPT BioRobotics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260289771-A1 | Conformal treatment planning using three-dimensional ultrasound | Pending | 18-Mar-2025 | ||
| WO-2026198472-A1 | Conformal treatment planning using three-dimensional ultrasound | Pending | 18-Mar-2025 | ||
| US-20260283696-A1 | Three-dimensional reconstruction of anatomical region using three-dimensional ultrasound | Pending | 18-Mar-2025 | ||
| EP-4832841-A1 | Image guided cancer treatment system and methods | Pending | 29-Dec-2023 | ||
| US-20250221774-A1 | Image guided cancer treatment system and methods | Pending | 29-Dec-2023 | G16H20/40 |
PROCEPT BioRobotics Signals
PROCEPT BioRobotics ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
27.98 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Devices
Subindustry
of 209
Rank
Percentile
PROCEPT BioRobotics FAQs
-
When was PROCEPT BioRobotics founded?
PROCEPT BioRobotics was founded in 2009.
-
Where is PROCEPT BioRobotics headquartered?
PROCEPT BioRobotics is headquartered in Redwood Shore, CA.
-
What is the size of PROCEPT BioRobotics?
PROCEPT BioRobotics has 888 total employees.
-
What industry is PROCEPT BioRobotics in?
PROCEPT BioRobotics’s primary industry is Surgical Devices.
-
Is PROCEPT BioRobotics a private or public company?
PROCEPT BioRobotics is a Public company.
-
What is PROCEPT BioRobotics’s stock symbol?
The ticker symbol for PROCEPT BioRobotics is PRCT.
-
What is the current stock price of PROCEPT BioRobotics?
As of 13-Nov-2026 the stock price of PROCEPT BioRobotics is $23.82.
-
What is the current market cap of PROCEPT BioRobotics?
The current market capitalization of PROCEPT BioRobotics is $1.37B.
-
What is PROCEPT BioRobotics’s current revenue?
The trailing twelve month revenue for PROCEPT BioRobotics is $352M.
-
Who are PROCEPT BioRobotics’s competitors?
Encision, Abbott, Medtronic, CooperSurgical, and Stryker are some of the 14 competitors of PROCEPT BioRobotics.
-
What is PROCEPT BioRobotics’s annual earnings per share (EPS)?
PROCEPT BioRobotics’s EPS for 12 months was -$2.02.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process